Chapter 5: Stem Cells: Potency, Niches & Regulation

Stem Cells: Potency, Niches & Regulation categorizes cellular potency, ranging from the totipotent zygote to pluripotent embryonic stem cells (ESCs) and multipotent adult stem cells, while emphasizing the pivotal role of the stem cell niche—a specialized microenvironment that regulates cell behavior through extracellular matrix adhesion, paracrine signaling, and intracellular transcriptional networks. The text details the molecular mechanisms governing the mammalian inner cell mass (ICM), where the transcription factors Oct4, Nanog, and Sox2 cooperate to maintain pluripotency, regulated by pathways such as Hippo and E-cadherin interactions. The analysis extends to invertebrate models, describing how Drosophila germline stem cells in the testes and ovaries rely on asymmetric division and signals like Unpaired (JAK-STAT) and BMP from somatic hub or cap cells to prevent premature differentiation. In adult mammalian systems, the chapter explores the neural stem cell (NSC) niche of the ventricular-subventricular zone (V-SVZ), highlighting the pinwheel architecture of radial glial-like B cells, the regulatory role of oscillating Notch signaling, and the impact of systemic factors like GDF11 and vascular interface on aging and neurogenesis, often studied through parabiosis experiments. The rapid turnover of the intestinal epithelium is examined through the lens of Lgr5-positive crypt base columnar cells (CBCCs), which reside in crypts alongside Paneth cells that provide essential Wnt signals, opposing the BMP gradients that drive differentiation and anoikis. Furthermore, the hematopoietic stem cell (HSC) niche in bone marrow is dissected, distinguishing between the quiescent endosteal niche and the active perivascular niche, both modulated by CXCL12 and sympathetic circadian rhythms. The versatility of mesenchymal stem cells (MSCs) is discussed regarding their ability to differentiate based on matrix elasticity. Finally, the chapter addresses the revolutionary impact of human model systems, contrasting naive and primed ESCs with induced pluripotent stem cells (iPSCs) reprogrammed via Yamanaka factors (Oct4, Sox2, Klf4, c-Myc), and reviewing advances in regenerative medicine, disease modeling for conditions like ALS and autism, and the creation of three-dimensional organoids, such as cerebral organoids, to mimic human organogenesis in vitro.